DK216681A - Fremgangsmaade til fremstilling af antitumormidler - Google Patents

Fremgangsmaade til fremstilling af antitumormidler

Info

Publication number
DK216681A
DK216681A DK216681A DK216681A DK216681A DK 216681 A DK216681 A DK 216681A DK 216681 A DK216681 A DK 216681A DK 216681 A DK216681 A DK 216681A DK 216681 A DK216681 A DK 216681A
Authority
DK
Denmark
Prior art keywords
antituum
procedures
agents
manufacture
antituum agents
Prior art date
Application number
DK216681A
Other languages
English (en)
Other versions
DK159376C (da
DK159376B (da
Inventor
M A Kaplan
D Bouzard
C Perol
J Stemer
A Weber
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DK216681A publication Critical patent/DK216681A/da
Publication of DK159376B publication Critical patent/DK159376B/da
Application granted granted Critical
Publication of DK159376C publication Critical patent/DK159376C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK216681A 1980-05-16 1981-05-14 Fremgangsmaade til fremstilling af et stabilt, fast, vandoploeseligt praeparat til rekonstituering med vand eller en vandig baerer som en stabil oploesning af 4'-(9-acridinylamino)methan-sulfon-m-anisid DK159376C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14705680 1980-05-16
US06/147,056 US4360523A (en) 1980-05-16 1980-05-16 Pharmaceutical formulations of 4'-(9-acridinylamino)-methanesulfon-m-anisidide

Publications (3)

Publication Number Publication Date
DK216681A true DK216681A (da) 1981-11-17
DK159376B DK159376B (da) 1990-10-08
DK159376C DK159376C (da) 1991-03-25

Family

ID=22520148

Family Applications (1)

Application Number Title Priority Date Filing Date
DK216681A DK159376C (da) 1980-05-16 1981-05-14 Fremgangsmaade til fremstilling af et stabilt, fast, vandoploeseligt praeparat til rekonstituering med vand eller en vandig baerer som en stabil oploesning af 4'-(9-acridinylamino)methan-sulfon-m-anisid

Country Status (21)

Country Link
US (1) US4360523A (da)
JP (1) JPS579716A (da)
AT (1) AT374682B (da)
AU (1) AU543726B2 (da)
BE (1) BE888832A (da)
CA (1) CA1160571A (da)
CH (1) CH647677A5 (da)
DE (1) DE3119510A1 (da)
DK (1) DK159376C (da)
FI (1) FI70793C (da)
FR (1) FR2482458A1 (da)
GB (1) GB2076288B (da)
GR (1) GR75658B (da)
IE (1) IE51285B1 (da)
IT (1) IT1170970B (da)
LU (1) LU83363A1 (da)
NL (1) NL8102362A (da)
NZ (1) NZ196985A (da)
SE (1) SE460457B (da)
YU (1) YU44831B (da)
ZA (1) ZA813188B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4575509A (en) * 1983-01-31 1986-03-11 Bristol-Myers Company Water-soluble formulations of m-AMSA with pyroglutamic acid
US4626541A (en) * 1985-09-12 1986-12-02 Bristol-Myers Company Water soluble salt composition of m-AMSA
DE3809814C1 (en) * 1988-03-23 1989-09-07 Karl Heinz Dr.Med. 7100 Heilbronn De Thiel Use of aminoacridines for iontophoretic treatment of bladder cancer
DE3819842C1 (da) * 1988-03-23 1989-12-21 Karl Heinz Dr. 7100 Heilbronn De Thiel
CA2143515A1 (en) * 1994-03-22 1995-09-23 Prakash Parab Method for enhancing the rate of skin permeation of lactic acid through use of the l-enantiomer
WO2006002887A1 (en) * 2004-06-29 2006-01-12 Baxter International Inc. Aqueous drink solution of indibulin (d-24851) and an organic acid
DE102004031538A1 (de) * 2004-06-29 2006-02-09 Baxter International Inc., Deerfield Pharmazeutische Darreichungsform zur oralen Verabreichung eines schwerlöslichen Wirkstoffs, Verfahren zu deren Herstellung und Kit
CA2587276A1 (en) * 2004-11-08 2006-05-18 Baxter International Inc. Nanoparticulate compositions of tubulin inhibitor compounds
CA2670778A1 (en) * 2006-11-28 2008-06-05 Ziopharm Oncology, Inc. Use of indolyl-3-glyoxylic acid derivatives including indibulin, alone or in combination with further agents for treating cancer
WO2015150383A1 (en) * 2014-03-31 2015-10-08 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Glycolic acid and/or d-lactic acid for the treatment of neurodegenerative diseases

Also Published As

Publication number Publication date
NZ196985A (en) 1983-06-17
YU112381A (en) 1985-03-20
ATA221181A (de) 1983-10-15
LU83363A1 (fr) 1982-01-20
US4360523A (en) 1982-11-23
FI811474L (fi) 1981-11-17
YU44831B (en) 1991-04-30
BE888832A (fr) 1981-11-16
DE3119510A1 (de) 1982-02-25
FR2482458A1 (fr) 1981-11-20
IE51285B1 (en) 1986-11-26
DE3119510C2 (da) 1991-03-07
IE811092L (en) 1981-11-16
AU543726B2 (en) 1985-05-02
CA1160571A (en) 1984-01-17
IT1170970B (it) 1987-06-03
AU7029181A (en) 1981-11-19
CH647677A5 (de) 1985-02-15
FI70793C (fi) 1986-10-27
GR75658B (da) 1984-08-02
FI70793B (fi) 1986-07-18
AT374682B (de) 1984-05-25
SE8103071L (sv) 1981-11-17
SE460457B (sv) 1989-10-16
FR2482458B1 (da) 1984-12-14
GB2076288B (en) 1983-12-14
IT8148467A1 (it) 1982-11-14
JPH0136445B2 (da) 1989-07-31
NL8102362A (nl) 1981-12-16
JPS579716A (en) 1982-01-19
ZA813188B (en) 1982-05-26
DK159376C (da) 1991-03-25
GB2076288A (en) 1981-12-02
IT8148467A0 (it) 1981-05-14
DK159376B (da) 1990-10-08

Similar Documents

Publication Publication Date Title
DK2281A (da) Fremgangsmaade til fremstilling af tiazolinderivater
DK300981A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK161581A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK150903C (da) Analogifremgangsmaade til fremstilling af benzisoselenazoloner
DK522081A (da) Fremgangsmaade til fremstilling af xanthater
DK100281A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK30781A (da) Fremgangsmaade til fremstilling af triazolidinderivater
DK154763C (da) Fremgangsmaade til fremstilling af norfloxacin
DK354281A (da) Fremgangsmaade til geninkorporering af kakaoaroma
DK34781A (da) Fremgangsmaade til fremstilling af phenylalkansyrederivater
DK172181A (da) Fremgangsmaade til fremstilling af 9-carbamoyl-9-aminoalkylfluoren-derivater
DK364481A (da) Fremgangsmaade til fremstilling af caprylolactamer
DK46781A (da) Fremgangsmaade til fremstilling af antirhinovirusmidler
DK296281A (da) Fremgangsmaade til fremstilling af aminocyklopentanonamider
DK343381A (da) Fremgangsmaade til fremstilling af urinstof
DK448981A (da) Fremgangsmaade til fremstilling af 4-chinolinmethanderivater
DK579181A (da) Fremgangsmaade til fremstilling af diarylthiophener
DK153841C (da) Fremgangsmaade til fremstilling af ranitidin
DK12581A (da) Fremgangsmaade til fremstilling af kijanimicin
DK199981A (da) Fremgangsmaade til fremstilling af thiobiscarbamater
DK273183A (da) Fremgangsmaade til fremstilling af amidiner
DK268981A (da) Fremgangsmaade til fremstilling af adeninnucleosidderivater
DK126181A (da) Fremgangsmaade til fremstilling af bicyclooctanforbindelser
DK21281A (da) Fremgansmaade til fremstilling af triazolderivater
DK296883D0 (da) Fremgangsmade til fremstilling af eburnanoximaetere